<DOC>
	<DOCNO>NCT02952898</DOCNO>
	<brief_summary>This research study do compare safety effectiveness GDC 695 ( test drug ) currently market reference drug ( diclofenac sodium gel , 3 % ) establish two drug work well placebo treatment actinic keratosis .</brief_summary>
	<brief_title>Study Comparing GDC 695 Diclofenac Sodium Gel , 3 % Subjects With Actinic Keratoses</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Has provide write informed consent . Immunocompetent male and/or nonpregnant female , 18 year age old . Willing able apply test article ( ) direct , comply study instruction , commit followup visit duration study . Clinical diagnosis actinic keratosis . In good general health free disease state physical condition . Women , must postmenopausal , surgically sterile , use effective method birth control negative urine pregnancy test ( UPT ) Baseline Visit ( Day 1 ) . Women pregnant , breastfeeding , plan become pregnant breastfeed study . Is currently enrol another investigational drug device study use investigational drug investigational device within 30 day prior Baseline Visit ( Day 1 ) . Has need plan expose artificial tanning device excessive sunlight study . Is immunosuppressed ( e.g. , human immunodeficiency virus [ HIV ] , systemic malignancy , graft host disease , etc . ) take medication suppress immune system . Has experience unsuccessful outcome previous topical diclofenac sodium therapy . Has history sensitivity ingredient test article excipients test reference drug . Has sign symptom consistent aspirin ( ASA ) triad . Has use topical medication : corticosteroid , alpha hydroxy acid ( e.g. , glycolic acid , lactic acid , etc . &gt; 5 % ) , beta hydroxy acid ( salicylic acid &gt; 2 % ) , urea &gt; 2 % , 5fluorouracil , diclofenac , imiquimod , ingenol mebutate , aminolevulinic acid ( ALA ) prescription retinoids ( e.g. , tazarotene , adapalene , tretinoin ) , overthecounter ( OTC ) product label scrub kind use smooth skin ( contain form exfoliant nut shell , coffee ground , polymer particle , etc . ) within select treatment area ( face bald scalp ) within one month prior Baseline Visit . Has cryodestruction chemodestruction , curettage , photodynamic therapy ( PDT ) , surgical excision , treatment AK within select treatment area ( face bald scalp ) within one month prior Baseline Visit . Has use oral corticosteroid therapy , interferon , cytotoxic drug , immunomodulators , immunosuppressive therapy , retinoids within one month prior Baseline Visit . Has use oral isotretinoin within six month prior Baseline Visit . Has use chemical peel , include limited alphahydroxy acid , betahydroxy acid , bichloroacetic acid , trichloroacetic acid , phenol within select treatment area ( face bald scalp ) within six month prior Baseline Visit . Has dermatologic procedure surgery : laser resurfacing , PUVA ( Psoralen + ultraviolet A ) therapy , ultraviolet B ( UVB ) therapy , ALAPDT , dermabrasion within select treatment area ( face bald scalp ) within six month prior Baseline Visit . Has lesion suspicious skin cancer ( skin cancer rule biopsy ) untreated skin cancer within select treatment area ( face bald scalp ) . Has active gastrointestinal ulceration bleed history gastrointestinal bleeds due use aspirin NSAIDs . Has severe renal hepatic impairment . Has condition , investigator 's opinion , could interfere evaluation test drug could make unsafe preclude subject 's ability fully participate research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>solar keratoses</keyword>
</DOC>